Investing.com - Financial Markets Worldwide

Genomma Lab Internacional SAB De CV (LABB)

Mexico
Symbol
Exchange
Currency
LABB·Mexico·MXN
GNMLF·OTC Markets·USD
Currency in MXN
20.910
+0.330(+1.60%)
Closed·

LABB Financial Summary

Key Ratios

P/E Ratio9.65
Price/Book1.85
Debt / Equity63.48%
Return on Equity20.67%
Dividend Yield3.89%
EBITDA4.27B
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
Income Statement
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa13,870.1515,487.0616,819.9116,467.1318,606.9
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa8,588.099,563.210,163.5510,083.2311,931.04
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa2,769.013,056.333,243.533,207.093,913.45
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa1,403.51,307.871,366.451,084.922,091.11
Balance Sheet
Total Assets
aa.aaaa.aaaa.aaaa.aaaa.aa21,340.8821,542.9621,606.5320,696.7223,017.8
Total Current Liabilities
aa.aaaa.aaaa.aaaa.aaaa.aa6,613.976,571.149,356.446,639.186,538.42
Total Equity
aa.aaaa.aaaa.aaaa.aaaa.aa8,842.4510,072.2310,152.59,382.7510,884.86
Cash Flow
Levered Free Cash Flow
aa.aaaa.aaaa.aaaa.aaaa.aa339.74525.71,828.892,387.261,220.03
Cash from Operations
aa.aaaa.aaaa.aaaa.aaaa.aa1,714.531,468.352,054.792,247.013,033.72
Cash from Investing
aa.aaaa.aaaa.aaaa.aaaa.aa-663.65-765.62-488.22-302.21-731.97
Cash from Financing
aa.aaaa.aaaa.aaaa.aaaa.aa189.85-1,469.24-1,362.4-1,676.82-1,591.04
Net Change in Cash
aa.aaaa.aaaa.aaaa.aaaa.aa1,180.93-839.0433.11190.39801.53
* In Millions of MXN (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 2.18%
Dividend Yield
3.89%
Industry Median 2.80%
Annualised payout
0.80
Paid unevenly
5-Years Growth
-
Growth Streak
Unlock

Analyst Ratings

3 Buy
2 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 30.200
(+44.43% Upside)

Earnings

Latest Release
Apr 30, 2025
EPS / Forecast
0.50 / 0.479
Revenue / Forecast
4.41B / 4.64B
EPS Revisions
a
a
Unlock
Last 90 days

FAQ

What were Genomma Lab Int's earnings for the latest quarter?

The Genomma Lab Int EPS (TTM) is 2.18. Genomma Lab Int reported sales of 4,406.33, net income of 498.72, and EPS of 0.50 for the latest quarter.

What was Genomma Lab Int's net income for the latest quarter?

Genomma Lab Int's net income for the latest quarter was 498.72.

How did Genomma Lab Int's performance compare year-over-year in the latest quarter?

The company's revenue moved from 4,665.57 in the previous quarter to 4,406.33 in the latest quarter, and net income moved from 427.30 to 498.72 compared to the previous quarter.

What is Genomma Lab Int's net profit margin on a TTM basis?

Genomma Lab Int's trailing twelve months (TTM) net profit margin is 11.24%.

How does Genomma Lab Int's debt to equity ratio compare to industry standards?

Genomma Lab Int's total debt-to-equity ratio is 63.48%.

What is Genomma Lab Int's return on investment on a TTM basis?

Genomma Lab Int's trailing twelve months (TTM) return on investment (ROI) is 20.67%.

Did Genomma Lab Int gain or lose cash last quarter?

In the latest quarter, Genomma Lab Int's net change in cash was -203.16 million.

What were Genomma Lab Int's total assets and liabilities in the latest quarter?

As of the latest quarter, Genomma Lab Int reported total assets of 24,080.38 million and total liabilities of 8,392.56 million.

How has Genomma Lab Int's total revenue grown this year?

Genomma Lab Int's total revenue was 4,665.57 in the previous quarter and 4,406.33 in the latest quarter.

What is Genomma Lab Int's gross margin on a TTM basis?

Genomma Lab Int's trailing twelve months (TTM) gross margin is 63.56%.

What was Genomma Lab Int's revenue per share for the latest quarter?

Genomma Lab Int's revenue per share for the latest quarter was 43.81.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.